US Markets

Mexico to start phase III clinical trials for China's Walvax COVID vaccine

Credit: REUTERS/China Daily CDIC

Mexico plans to start phase III clinical trials for China's Walvax Biotechnology's COVID-19 vaccine on May 30 and 6,000 volunteers are expected to participate, foreign minister Marcelo Ebrard said on Tuesday.

MEXICO CITY, May 11 (Reuters) - Mexico plans to start phase III clinical trials for China's Walvax Biotechnology's 300142.SZ COVID-19 vaccine on May 30 and 6,000 volunteers are expected to participate, foreign minister Marcelo Ebrard said on Tuesday.

(Reporting by Anthony Esposito; Editing by Andrew Heavens)

((anthony.esposito@tr.com; +5255 5282 7140;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos

    Reuters

    Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

    Learn More